Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?
- 1 January 2001
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (2), 153-159
- https://doi.org/10.1097/00002030-200101260-00003
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug usersAIDS, 1999
- Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing complianceAIDS Care, 1996
- Zidovudine adherence among individuals with HIV infectionAIDS Care, 1995
- Pipes, Colanders, and Leaky Buckets: Reflections on the Futility DebateCambridge Quarterly of Healthcare Ethics, 1993
- Futility: Is Definition the Problem? Part ICambridge Quarterly of Healthcare Ethics, 1993
- Physicians and Futile Care: Using Ethics Committees to Slow the MomentumLaw, Medicine and Health Care, 1992
- Futility: A Concept in Search of a DefinitionLaw, Medicine and Health Care, 1992
- Who defines futility?Published by American Medical Association (AMA) ,1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical careArchives of Internal Medicine, 1977